| Name | Title | Contact Details |
|---|
Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.
The best inpatient drug rehabs Los Angeles options offering evidence-based, personalized addiction treatment. Our alcohol detox centers LA
Aequor Healthcare is a Piscataway, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Integra ServiceConnect is a non-clinical healthcare service company that connects people to service that improves their health. Specializing in community-based non-clinical support for individuals with healthcare and related social service needs, the Owings Mills, Md.-based company helps health plans, health systems and government organizations find, engage and connect underserved members to care that can preserve and improve their health. Integra has been providing community-based services for individuals with complex healthcare needs for more than two decades.
Great Lakes Health Plan, Inc. is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.